Endonovo Therapeutics, Inc.

8-K Entered a material agreement Jan 3, 2024 10-Q/A Quarter ended 2023-09-30 Dec 29, 2023 10-Q Quarter ended 2023-09-30 Dec 29, 2023 8-K Entered a material agreement Dec 4, 2023 8-K Other events Oct 12, 2023 10-Q Quarter ended 2023-06-30 Aug 21, 2023 10-Q Quarter ended 2023-03-31 May 22, 2023 10-K Fiscal year ended 2022-12-31 Apr 17, 2023 8-K Entered a material agreement Mar 29, 2023 10-Q Quarter ended 2022-09-30 Nov 21, 2022 8-K Entered a material agreement Sep 27, 2022 10-Q Quarter ended 2022-06-30 Aug 22, 2022 10-Q Quarter ended 2022-03-31 May 19, 2022 10-K Fiscal year ended 2021-12-31 Apr 14, 2022 10-Q Quarter ended 2021-09-30 Nov 19, 2021 10-Q Quarter ended 2021-06-30 Aug 23, 2021 10-Q Quarter ended 2021-03-31 May 24, 2021 10-K Fiscal year ended 2020-12-31 Apr 13, 2021 10-Q Quarter ended 2020-09-30 Nov 19, 2020 10-Q Quarter ended 2020-06-30 Aug 19, 2020 8-K Director or officer change Aug 7, 2020 10-Q Quarter ended 2020-03-31 Jun 12, 2020 8-K Entered a material agreement May 26, 2020 8-K Other events May 19, 2020 10-K Fiscal year ended 2019-12-31 May 4, 2020 8-K Other events Apr 10, 2020 8-K Other events Mar 2, 2020 8-K Modified rights of security holders Feb 3, 2020 8-K Modified rights of security holders Dec 19, 2019 10-Q Quarter ended 2019-09-30 Nov 19, 2019 10-Q Quarter ended 2019-06-30 Aug 13, 2019 8-K Other events Jun 13, 2019 10-Q Quarter ended 2019-03-31 May 9, 2019 10-K Fiscal year ended 2018-12-31 Apr 15, 2019 8-K Entered a material agreement Jan 3, 2019 8-K Entered a material agreement Dec 7, 2018 10-Q Quarter ended 2018-09-30 Nov 13, 2018 8-K Modified rights of security holders Sep 24, 2018 8-K Entered a material agreement Aug 14, 2018 10-Q Quarter ended 2018-06-30 Aug 13, 2018